This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Münster. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Moumita Koley
Introduction
Moumita Koley is a prominent inventor based in Bengaluru, India. She has made significant strides in the field of pharmaceuticals, particularly in the development of compounds that have the potential to revolutionize cardiac treatment. Her work focuses on inducing cardiomyogenesis, which is crucial for heart health.
Latest Patents
Moumita Koley holds a patent for "Substituted pyridines and pyrimidines." This patent includes compounds of formula (I) and/or salts thereof, which are useful for inducing cardiomyogenesis. The process involves producing cardiomyocyte-like cells from mammalian cells by culturing them in the presence of the compound of formula (I). The pharmaceutical applications of these compounds are aimed at treating disorders associated with impaired heart function.
Career Highlights
Throughout her career, Moumita has worked with esteemed institutions such as Technische Universität Wien. Her research has contributed to advancements in the understanding of cardiac cell development and treatment methodologies.
Collaborations
Moumita has collaborated with notable professionals in her field, including Marko Mihovilovic and Michael Schnuerch. These collaborations have further enhanced her research and innovation capabilities.
Conclusion
Moumita Koley's contributions to the field of cardiomyogenesis and her innovative patent highlight her role as a leading inventor in the pharmaceutical industry. Her work has the potential to significantly impact heart disease treatment and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile